Workflow
Trendlines(TRNLY)
icon
Search documents
收评:突破下降趋势线,若量能不济短调随时会来,3260一线已不宜再失
Sou Hu Cai Jing· 2025-04-21 23:36
Group 1 - The market showed a small upward trend with the index closing above 3287, indicating a short-term bullish sentiment despite medium-term concerns [2] - The key resistance level is identified at 3300, with a need to maintain above 3260 to avoid further declines [2][3] - The trading volume increased moderately, suggesting a potential shift in market sentiment as it broke the descending trend line formed since 3439 [2] Group 2 - The short-term technical indicators suggest that the market must stay above 3276 to maintain a bullish outlook, with critical zones identified between 3275 and 3307 [3] - The pressure points for the market are set at 3298, 3307, and 3317, while support levels are at 3280, 3270, and 3260 [4] - The mid to long-term outlook indicates that the market must remain above the 60-day moving average to sustain a bullish trend, with the 250-day moving average serving as a critical threshold to avoid a bearish reversal [4]
突破趋势线,小散回血,这一仗打得漂亮
Sou Hu Cai Jing· 2025-04-21 12:18
今天低开在3273,最低3270,最高3298,收盘在3291。个股涨跌家数比4363:875,普涨。 今天在面临日级别有调整要求的情况下,不仅创了反弹新高,还攻击了3300附近的颈线位3297,可以说总体上是表现不错的,不得不说这是面对3439调整 以来形成的下降趋势线多头主力势在必得的一种态度,因为一旦在此处犯怂的话,那就很可能被空头借力发动一波反扑。总的来说,在上周五盘后多头优 势已很微弱的局面下,多头大资金(那只"无形之手")今天这一仗打得还是很漂亮的,调动了量化的助力。 从盘中表现来看,攻击3300附近回落后基本上是在3285横盘振荡的,这也是我直播里非常希望看到的局面。而从个股来说,大票先带领攻击了一波,后面 也是我直播里希望出现的大票歇脚小票开始表现,挺好,可以让小散们回点血,这对凝聚人气是好处多多的。再有一点就是成交量,这是周评里特别强调 的能否突破下降趋势线的关键因素,在技术面有调整要求的情况下,要想继续上攻,那必须由成交量推动才能实现,而今天是在缺少北向资金的情况下放 出来的,很难得啊。 短期而言,一旦量能不济短调随时会来。继续关注3300附近和10日线的得失即可。 中期态势:已见底,转好 ...
午评:盘中突破了3439以来形成的下降趋势线,注意成交量和收盘结果吧
Sou Hu Cai Jing· 2025-04-21 06:30
Group 1 - The market showed a tendency to rise after a slight opening decline, with more stocks gaining than losing, indicating bullish control in the short term [2] - Key resistance is noted around the 3300 level, with support at the 10-day moving average; a stable position above 3260 could improve the outlook [2] - The market needs to break above 3300 with sufficient trading volume to confirm a stronger upward trend, while maintaining levels above 3265-3261 is crucial to avoid further declines [2][3] Group 2 - The short-term technical outlook indicates that the market must stay above the life line at 3276 to maintain a bullish stance, with critical zones identified between 3272 and 3307 [3] - A closing above 3287 is acceptable, while a close above 3297 is preferred, and a strong close above 3307 is necessary for bullish momentum [3] - The mid to long-term outlook suggests that the key resistance levels are between 3350-3380 for the weekly chart and 3320-3360 for the monthly chart, with the market needing to stay above the 60-day and 250-day moving averages to avoid bearish conditions [3]
周评:突破下跌趋势线的机会出现,能否抓住得看成交量了
Sou Hu Cai Jing· 2025-04-20 09:35
Core Viewpoint - The current market situation is characterized as neither bullish nor bearish, with a mid-term downtrend but a short-term bullish advantage. The decision on market direction may depend on external factors rather than just technical indicators [1][5]. Technical Analysis - The market needs to close above 3310 to be acceptable, above 3330 for a positive outlook, and above 3350 for a strong bullish signal. A close above 3290 is necessary for stability [2][9]. - The weekly chart shows a small bullish candle with a closing price of 3276, indicating a 1.19% increase. However, the mid-term outlook remains negative while the short-term shows slight bullishness [2][4]. - The weekly technical indicators suggest a mid-term downtrend, with MACD lines diverging downwards and KDJ lines showing a bearish crossover. The market is currently below key moving averages [4][8]. - A breakthrough of the downtrend line is possible if the trading volume supports it. The market must close above 3281 to break the downtrend established since 3439 [5][8]. Support and Resistance Levels - Key resistance levels are identified at 3285, 3297, and strong resistance between 3319 and 3342. Support levels are at 3258, 3247, with strong support between 3233 and 3193 [11]. - The critical threshold for market strength is at 3307, with various levels indicating bullish or bearish dominance based on closing prices [10][9]. Trading Strategy - The recommended trading strategy involves oscillating between the upper and lower gaps, with a focus on filling the upper gap for bullish positions and the lower gap for bearish positions [7].
美股仍被严重高估!“巴菲特指标”超历史趋势线35个百分点 瑞银唱衰:美股吸引力不再!
Mei Ri Jing Ji Xin Wen· 2025-04-07 07:34
Group 1 - The market is warned of a potential "Black Monday" reminiscent of the 1987 crash, with significant declines in major indices [1][3] - On April 4, the S&P 500 index fell nearly 6%, marking its largest single-day drop since March 16, 2020, and is down 17% from its February peak [1] - The Dow Jones Industrial Average dropped 5.5%, the largest single-day decline since June 11, 2020, while the Nasdaq Composite fell 5.82%, entering a technical bear market with a cumulative drop of over 20% from its December peak [1] Group 2 - Despite the recent declines, U.S. stock valuations remain significantly overvalued, with the Buffett Indicator at 170%, exceeding the historical trend line by 34.5 percentage points [2][6] - The Buffett Indicator measures the ratio of U.S. stock market capitalization to GDP, with the current Wilshire 5000 index at $50.559 trillion and the latest annualized GDP at $29.724 trillion [6] - UBS downgraded U.S. stocks from "attractive" to "neutral," citing potential economic recession and significant market declines if tariffs are not addressed [12] Group 3 - The possibility of a market circuit breaker is being discussed, which would halt trading if the S&P 500 index falls by certain thresholds [8][9][10] - The thresholds for circuit breakers are set at 7% (level 1), 13% (level 2), and 20% (level 3) declines, with specific point levels identified for the S&P 500 [11] Group 4 - Market expectations for Federal Reserve interest rate cuts have increased from three to five times within the year, with the next cut anticipated in May [14] - UBS forecasts U.S. GDP growth to slow to below 1%, with potential recession risks and inflation impacts from tariff policies complicating Fed decisions [14]
XBIT交易所量子加密护航XLM生态恒星币突破关键趋势线
Sou Hu Cai Jing· 2025-03-28 13:33
恒星币生态扩张与市场表现:技术整合驱动跨境金融革新 恒星网络近期完成多项战略升级,其核心协议SCP(恒星共识协议)通过联邦拜占庭算法实现4秒交易 确认,日均处理量突破500万笔。2025年3月,恒星发展基金会(SDF)宣布与DIA、Pelago Labs达成技 术合作,集成Lumina数据预言机系统,使代币化应收账款与USDC稳定币实现链上自动清算。与此同 时,Ondo Finance将USDY收益型稳定币引入恒星网络,通过XLM桥接资产提升跨境支付效率。市场交 易层面,XLM在XBIT、币安等平台的周交易量环比增长22%,其中机构账户占比提升至18%。链上数 据显示,XLM质押量突破12亿枚,年化收益率为4.8%,较以太坊质押收益高0.7个百分点。价格走势方 面,XLM自3月11日0.245美元启动上升通道,四次回踩趋势线后形成0.285美元强支撑,当前RSI指标处 于54中性区间,MACD呈多头收敛形态,若突破0.3美元心理关口,有望冲击0.33美元年度高位。 图片来源:币界网 来源:科普新视角 截至2025年3月28日,恒星币(XLM)实时价格约为0.28美元,市值87.5亿美元,位列第15位。近期 X ...
Limaca's Precision-GI™ Enters US Market
Prnewswire· 2025-02-18 13:00
CMS Transitional Pass-Through (TPT) Payment and completion of successful clinical studies position Limaca for US market entry. YOKNEAM, Israel, Feb. 18, 2025 /PRNewswire/ -- Limaca Medical Ltd. ("Limaca") has launched its Precision-GI™ endoscopic automated motorized EUS biopsy device in the US market. Commercialization is supported by Limaca's clinical trials, operational capabilities, FDA clearance, and CMS Transitional Pass-Through (TPT) Payment award. Pictured from left to right: Michael Davis, Sales ...
Varana Capital Leads Arcuro Medical's Series A Financing, Driving Strategic Growth in 2025
Prnewswire· 2025-01-06 15:41
Company Overview - Arcuro Medical Ltd. is a portfolio company of The Trendlines Group, headquartered in Israel with operations in the U.S. [4] - The company specializes in developing and manufacturing minimally invasive orthopedic products, focusing on innovative medical devices [4]. - Arcuro Medical aims to improve patients' lives through game-changing technologies in sports medicine [4]. Investment Details - Varana Capital is the lead investor in Arcuro Medical's Series A financing round, which is currently open for additional investment [1]. - The funding will support Arcuro's growth and innovation in the medical device industry [1]. - Other notable investors in this round include Trendlines and Consensus Business Group [1]. Strategic Goals and Achievements - Arcuro Medical concluded 2024 with significant achievements, including the establishment of a new U.S. organization and hiring key sales leadership [5]. - The company added new U.S. and international distribution partners and achieved a significant product development milestone with the 510(k) submission of a new product line [5]. - Arcuro Medical surpassed 5,000 global SuperBall cases, positioning itself for substantial growth in 2025 [5]. Upcoming Events - Arcuro Medical will present at the MSK Innovations Pitch Event on January 8, 2025, providing insights into the company's vision and advancements [3].
GE Aerospace Stock Could Bounce Off Bullish Trendlines
Schaeffers Investment Research· 2024-11-08 17:20
Subscribers to Schaeffer's Weekend Trader options recommendation service received this GE commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters. Learn more about why Weekend Trader is one of our most popular options trading services.Shares of GE Aerospace (NYSE:GE) recently cleared their 2005 and 2017 highs, and are pulling back to their 20-week and 126-day moving averages, both of which have led to outsized gains. Concerning the latte ...
ElastiMed Welcomes Dr. Amir Belson as a Member of the Board of Directors
Prnewswire· 2024-10-28 12:00
Core Insights - ElastiMed Ltd. has appointed Dr. Amir Belson to its Board of Directors, enhancing its leadership in the wearable medical device sector [1][4] - Dr. Belson brings extensive experience in the medical device industry, having founded and led several successful companies that were acquired by major players [2][3] - His appointment is timely as ElastiMed aims to bring its innovative compression therapy devices to market, targeting millions suffering from lymphatic and venous diseases [3][4] Company Overview - ElastiMed specializes in wearable medical devices designed to treat and manage lymphatic and venous diseases, focusing on innovation and patient empowerment [5] - The company is committed to improving patient outcomes and addressing health equity challenges while enhancing healthcare delivery at home [5][6] - ElastiMed is a portfolio company of The Trendlines Group Ltd. and has received funding from various sources, including the Israeli Innovation Authority and Horizon 2020 [6]